ROR1蛋白:在癌症进展和治疗的十字路口的一个伪激酶
Shradheya R R Gupta1, Rashmi Rameshwari2, Indrakant Kumar Singh3,4,5
1Department of Biotechnology, School of Engineering and Technology (SET), Manav Rachna International Institute of Research and Studies (MRIIRS), Faridabad, Haryana, 121004, India.
类似氨酸激酶受体的孤儿受体1 (ROR1) 是一种在癌症中至关重要的伪激酶. 准ROR1为开发针对各种恶性瘤的新型抗癌疗法提供了一个有前途的战略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 伪基因酶调节细胞过程,尽管缺乏酶活性.
- 类似氨酸激酶受体的孤儿受体1 (ROR1) 是一种伪激酶,涉及到癌症生物学.
- ROR1在许多癌症中异常表达,但在正常的成年组织中没有.
研究的目的:
- 提供ROR1的结构和功能特征的深入分析.
- 探索ROR1与瘤信号通路的相互作用及其在瘤进展中的作用.
- 审查针对ROR1.1的当前和新兴治疗策略.
主要方法:
- 关于ROR1在癌症中的作用的文献综述和分析.
- 检查ROR1的结构和功能属性.
- 评估治疗策略,包括抗体,ADC,CAR T细胞疗法和小分子抑制剂.
主要成果:
- ROR1驱动瘤的存活,转移,治疗耐药性和干性.
- ROR1与关键的瘤原体信号通路相互作用.
- 针对ROR1的各种治疗方式显示出临床潜力.
结论:
- 由于其致癌作用和独特的表达,ROR1是瘤学的重要治疗点.
- 开发有效的抗癌策略需要了解ROR1的机制,并克服治疗挑战.
- 准ROR1对治疗血液癌症和固体瘤具有前途.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
